A recent study suggests that people who come off new weight-loss injections like semaglutide or tirzepatide tend to recover reduced body mass much more quickly than those who end conventional diet and exercise regimens.
Research printed in a leading health publication demonstrates that while overweight people can lose a large proportion of their total mass while using the jabs, the mass returns at an estimated rate of nearly a kilo each month once they quit.
"Individuals buying such treatments should be aware of the potential of rapid rebound weight gain when the therapy ends," warns expert Dr. Susan Jebb.
This pace of recovery means a reversion to starting weight within about one and a half years.
Comparing Treatments
The study, which reviewed dozens of trials involving thousands of patients, contrasted the outcomes of the injectable medications with conventional dieting.
Scientists point out that people who shed pounds through diet and exercise usually see a less rapid creep back—around 100 grams monthly—after stopping.
Understanding the Fast Regain
Doctors believe the mechanism of the injections is key to understanding the accelerated regain.
These medications imitate a natural hormone called GLP-1, which controls hunger.
"Sustained high doses of GLP-1 levels far above than normal may cause the body to produce less of its own natural GLP-1, and may also diminish sensitivity to its actions," noted Dr. Adam Collins, a nutrition specialist.
"Discontinuation of this GLP-1 'fix' means appetite is no longer kept in check, making excessive eating a significant risk."
A Chronic Condition?
Medical guidelines recommend the injections for individuals with obesity-related medical conditions, alongside recommended diet and exercise modifications.
A number of clinicians say that, considering the likelihood of relapse, the therapy might need to be ongoing.
This opinion is reinforced by drug manufacturers, who note that the results "underscore the persistent nature of excess weight," similar to managing conditions like high blood pressure.
User Testimonies
Users who have discontinued the jabs explain a powerful return of appetite.
"I experienced a switch that goes on and I was suddenly starving," said an individual.
This difficulty is compounded if patients have not adopted sustainable lifestyle or habit modifications during treatment.
Significant Adoption
Survey data show that millions of people in the UK have tried weight-loss jabs in the last 12 months, with demand continuing to grow.
- Use is greater among women compared to men.
- The 40s and 50s age group shows the highest level of interest.
- Many access the medications through private prescriptions rather than the NHS.
Finally, clinicians stress that while the jabs are effective agents for shedding pounds, they are not a standalone solution and lasting health benefits hinges on integrated lifestyle changes.
